Trials / Completed
CompletedNCT01275092
Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)
CorPath® PRECISE Percutaneous Robotically-Enhanced Coronary Intervention Study (PRECISE)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 164 (actual)
- Sponsor
- Corindus Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the safety and effectiveness of the clinical and technical performance of the CorPath® 200 System in the delivery and manipulation of coronary guidewires and stent/balloon systems for use in percutaneous coronary interventions (PCI).
Conditions
- Coronary Artery Disease
- Coronary Disease
- Myocardial Ischemia
- Heart Diseases
- Cardiovascular Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Vascular Diseases
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CorPath robotic-assisted PCI | CorPath 200® robotic-assisted percutaneous coronary intervention |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2011-12-01
- Completion
- 2012-01-01
- First posted
- 2011-01-12
- Last updated
- 2013-08-08
- Results posted
- 2013-08-08
Locations
9 sites across 2 countries: United States, Colombia
Source: ClinicalTrials.gov record NCT01275092. Inclusion in this directory is not an endorsement.